2024

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

2023

Stubbs, H., Lua, S., Ingram, J., Jani, B. D. , Brewis, M., Church, C. and Johnson, M. (2023) Remote exercise testing in pulmonary hypertension (PHRET). Pulmonary Circulation, 13(4), e12325. (doi: 10.1002/pul2.12325) (PMID:38148951) (PMCID:PMC10749888)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Arogundade, F., Jani, B. , Church, C., Brewis, M., Johnson, M. and Stubbs, H. (2023) The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: a retrospective longitudinal cohort study. Pulmonary Circulation, 13(3), e12257. (doi: 10.1002/pul2.12257) (PMID:37404903) (PMCID:PMC10315452)

Stubbs, H., MacLellan, A., Lua, S., Dormand, H. and Church, C. (2023) The right ventricle under pressure: anatomy and imaging in sickness and health. Journal of Anatomy, 242(1), pp. 17-28. (doi: 10.1111/joa.13654) (PMID:35285014) (PMCID:PMC9773164)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

2022

McGettrick, M., Dormand, H., Brewis, M., Johnson, M. K., Lang, N. N. and Church, A. C. (2022) Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease. Frontiers in Cardiovascular Medicine, 9, 1004169. (doi: 10.3389/fcvm.2022.1004169) (PMID:36582741) (PMCID:PMC9793745)

Stubbs, H., Brewis, M., Church, C. and Johnson, M. (2022) Towards telemedicine in pulmonary hypertension: assessing the feasibility of remote quality of life and exercise capacity assessment. Pulmonary Circulation, 12(4), e12144. (doi: 10.1002/pul2.12144) (PMID:36381292) (PMCID:PMC9647124)

Stubbs, H. , Lua, S., Brewis, M., Johnson, M. and Church, C. (2022) COMPERA 2.0 risk stratification in medically managed chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 60, 2200313. (doi: 10.1183/13993003.00313-2022) (PMID:35798358)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Stubbs, H., MacLellan, A., McGettrick, M., Jani, B. , Brewis, M., Church, C. and Johnson, M. (2022) Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland. Open Heart, 9(1), e002023. (doi: 10.1136/openhrt-2022-002023) (PMID:35477699) (PMCID:PMC9047890)

Rhodes, C. J. et al. (2022) Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 205(9), pp. 1102-1111. (doi: 10.1164/rccm.202105-1118oc) (PMID:35081018)

2021

Norton, L. et al. (2021) Clinical and radiological characteristics of acute pulmonary embolus in relation to 28-day and 6-month mortality. PLoS ONE, 16(12), e0258843. (doi: 10.1371/journal.pone.0258843) (PMID:34962922) (PMCID:PMC8714121)

Kariotis, S. et al. (2021) Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nature Communications, 12, 7104. (doi: 10.1038/s41467-021-27326-0)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C. , Wong, I. C.K., Berry, C. , Sattar, N. and Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96(10), pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002) (PMID:34607634) (PMCID:PMC8282478)

Stubbs, H. , Church, C., Johnson, M. and Thomson, S. D. (2021) Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension. ERJ Open Research, 7, 00449-2021. (doi: 10.1183/23120541.00449-2021) (PMID:34476249) (PMCID:PMC8405871)

McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N. , Johnson, M.K. and Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, e050281. (doi: 10.1136/bmjopen-2021-050281) (PMID:34462282)

2020

Wilson, K. S. et al. (2020) Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation, 10(2), (doi: 10.1177/2045894020922810)

2015

Menni, C. et al. (2015) Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension, 66, pp. 422-429. (doi: 10.1161/HYPERTENSIONAHA.115.05544) (PMID:26034203) (PMCID:PMC4490909)

2013

Bayes, H.K., Church, A.C. and Fisher, A.J. (2013) Review of the British Thoracic Society Winter meeting 2012, 5 to 7 December, London, UK. Thorax, 68(3), pp. 277-282. (doi: 10.1136/thoraxjnl-2012-203165)

2012

Bayes, H., Church, A. and Fisher, A.J. (2012) Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, UK. Thorax, 67(3), pp. 258-262. (doi: 10.1136/thoraxjnl-2012-201597)

2009

Church, A., Sivasothy, P., Parmer, J. and Foweraker, J. (2009) Mediastinal, Abscess After Lung Transplantation Secondary to Burkholderia gladioli Infection. Journal of Heart and Lung Transplantation, 28(5), pp. 511-514.

Articles

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Stubbs, H., Lua, S., Ingram, J., Jani, B. D. , Brewis, M., Church, C. and Johnson, M. (2023) Remote exercise testing in pulmonary hypertension (PHRET). Pulmonary Circulation, 13(4), e12325. (doi: 10.1002/pul2.12325) (PMID:38148951) (PMCID:PMC10749888)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Arogundade, F., Jani, B. , Church, C., Brewis, M., Johnson, M. and Stubbs, H. (2023) The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: a retrospective longitudinal cohort study. Pulmonary Circulation, 13(3), e12257. (doi: 10.1002/pul2.12257) (PMID:37404903) (PMCID:PMC10315452)

Stubbs, H., MacLellan, A., Lua, S., Dormand, H. and Church, C. (2023) The right ventricle under pressure: anatomy and imaging in sickness and health. Journal of Anatomy, 242(1), pp. 17-28. (doi: 10.1111/joa.13654) (PMID:35285014) (PMCID:PMC9773164)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

McGettrick, M., Dormand, H., Brewis, M., Johnson, M. K., Lang, N. N. and Church, A. C. (2022) Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease. Frontiers in Cardiovascular Medicine, 9, 1004169. (doi: 10.3389/fcvm.2022.1004169) (PMID:36582741) (PMCID:PMC9793745)

Stubbs, H., Brewis, M., Church, C. and Johnson, M. (2022) Towards telemedicine in pulmonary hypertension: assessing the feasibility of remote quality of life and exercise capacity assessment. Pulmonary Circulation, 12(4), e12144. (doi: 10.1002/pul2.12144) (PMID:36381292) (PMCID:PMC9647124)

Stubbs, H. , Lua, S., Brewis, M., Johnson, M. and Church, C. (2022) COMPERA 2.0 risk stratification in medically managed chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 60, 2200313. (doi: 10.1183/13993003.00313-2022) (PMID:35798358)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Stubbs, H., MacLellan, A., McGettrick, M., Jani, B. , Brewis, M., Church, C. and Johnson, M. (2022) Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland. Open Heart, 9(1), e002023. (doi: 10.1136/openhrt-2022-002023) (PMID:35477699) (PMCID:PMC9047890)

Rhodes, C. J. et al. (2022) Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 205(9), pp. 1102-1111. (doi: 10.1164/rccm.202105-1118oc) (PMID:35081018)

Norton, L. et al. (2021) Clinical and radiological characteristics of acute pulmonary embolus in relation to 28-day and 6-month mortality. PLoS ONE, 16(12), e0258843. (doi: 10.1371/journal.pone.0258843) (PMID:34962922) (PMCID:PMC8714121)

Kariotis, S. et al. (2021) Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nature Communications, 12, 7104. (doi: 10.1038/s41467-021-27326-0)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C. , Wong, I. C.K., Berry, C. , Sattar, N. and Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96(10), pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002) (PMID:34607634) (PMCID:PMC8282478)

Stubbs, H. , Church, C., Johnson, M. and Thomson, S. D. (2021) Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension. ERJ Open Research, 7, 00449-2021. (doi: 10.1183/23120541.00449-2021) (PMID:34476249) (PMCID:PMC8405871)

McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N. , Johnson, M.K. and Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, e050281. (doi: 10.1136/bmjopen-2021-050281) (PMID:34462282)

Wilson, K. S. et al. (2020) Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation, 10(2), (doi: 10.1177/2045894020922810)

Menni, C. et al. (2015) Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension, 66, pp. 422-429. (doi: 10.1161/HYPERTENSIONAHA.115.05544) (PMID:26034203) (PMCID:PMC4490909)

Bayes, H.K., Church, A.C. and Fisher, A.J. (2013) Review of the British Thoracic Society Winter meeting 2012, 5 to 7 December, London, UK. Thorax, 68(3), pp. 277-282. (doi: 10.1136/thoraxjnl-2012-203165)

Bayes, H., Church, A. and Fisher, A.J. (2012) Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, UK. Thorax, 67(3), pp. 258-262. (doi: 10.1136/thoraxjnl-2012-201597)

Church, A., Sivasothy, P., Parmer, J. and Foweraker, J. (2009) Mediastinal, Abscess After Lung Transplantation Secondary to Burkholderia gladioli Infection. Journal of Heart and Lung Transplantation, 28(5), pp. 511-514.